(PharmaNewsWire.Com, July 31, 2019 ) The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices.
The thawing system market is expected to reach USD 252.7 Million by 2022 from USD 124.1 Million in 2016, at a CAGR of 12.6%.
Market Dynamics
+ Drivers
+ Rising Focus of Biorepositories on Expanding Their Storage Capacities
+ Technological Advancements in Sample Thawing Devices
+ Rising Use of Thawed Cells in the Study and Treatment of Diabetes and Cancer
The thawing system market is classified into manual and automated devices. The manual devices segment is expected to lead the global thawing system market in 2017. Factors driving the growth of this segment include low cost and wider availability of manual devices across the globe.
The market is segmented into blood, embryos, semen, ovum, and other samples (nucleic acids and human tissues). The blood sample segment is anticipated to account for the largest share of the global thawing system market in 2017. Rising incidence of blood disorders and increasing demand for various types of blood products are major factors responsible for the large share of this segment.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
